BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Biotech Beach

  Biosense Webster, Inc. Launches Outcomes-Based, Risk-Sharing Program To Reinforce Significant Patient Benefits Demonstrated By Company’s Leading Contact Force Therapy

  December 19, 2014

   · 

  1 min read
• Business

  Cytori Therapeutics, Inc. And Biomedical Advanced Research and Development Authority (BARDA) Amend Contract Option To Accelerate The Advancement Of A Thermal Burn Injury Countermeasure

  December 19, 2014

   · 

  4 min read
• Biotech Beach

  Ligand Pharmaceuticals Inc. Partner Pfizer Receives European Marketing Authorization For DUAVIVE® (Conjugated Estrogens/Bazedoxifene) For Treatment Of Estrogen Deficiency Symptoms In Postmenopausal Women With A Uterus

  December 19, 2014

   · 

  4 min read
• FDA

  Teva Pharmaceutical Industries Limited Announces FDA Approval Of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol For Treatment Of Children With Seasonal And Perennial Allergic Rhinitis

  December 19, 2014

   · 

  11 min read
• BioMidwest

  BrainLAB AG Multiple Metastases Planning And Other Revolutionary Software Applications Now Available In The United States

  December 19, 2014

   · 

  2 min read
• Business

  BTG plc: Appointment Of Non-Executive Director

  December 19, 2014

   · 

  1 min read
• Pharm Country

  Relmada Therapeutics Announces Results Of Annual Shareholders Meeting

  December 19, 2014

   · 

  3 min read
• Business

  RXi Pharmaceuticals Expands Its Clinical Pipeline With An Exclusive Global License For A Second Phase 2 Clinical Compound

  December 19, 2014

   · 

  9 min read
• Business

  Ohr Pharmaceutical To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22

  December 19, 2014

   · 

  3 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Results From The Phase 2 Borealis-1 Trial Of Apatorsen In The Treatment Of Metastatic Bladder Cancer

  December 19, 2014

   · 

  7 min read